scispace - formally typeset
D

Diana K. Meza

Researcher at University of Glasgow

Publications -  7
Citations -  46

Diana K. Meza is an academic researcher from University of Glasgow. The author has contributed to research in topics: Rabies & Rabies virus. The author has an hindex of 4, co-authored 5 publications receiving 21 citations.

Papers
More filters
Journal ArticleDOI

Temporal patterns of vampire bat rabies and host connectivity in Belize

TL;DR: The analyses suggest frequent transmission of rabies virus within and among vampire bat roosts in northern Belize and highlight the need for future spatiotemporal, phylogenetic and ecological studies of vampire bat rabies in Central America.
Journal ArticleDOI

Epidemiology and biology of a herpesvirus in rabies endemic vampire bat populations.

TL;DR: This work investigates the biological and epidemiological suitability of a vampire bat betaherpesvirus (DrBHV) to act as a vaccine vector for a transmissible rabies vaccine, and provides a framework to discover and evaluate candidate viral vectors for vaccines against bat-borne zoonoses.
Journal ArticleDOI

Predicting the presence and titre of rabies virus-neutralizing antibodies from low-volume serum samples in low-containment facilities.

TL;DR: An existing micro-neutralization test is adapted to use a green fluorescent protein-tagged murine leukemia virus pseudotype in lieu of pathogenic rabies virus, reducing the need for specialized reagents for antigen detection and enabling use in low-containment laboratories.
Journal ArticleDOI

Ecological determinants of rabies virus dynamics in vampire bats and spillover to livestock

TL;DR: This article studied patterns of rabies exposure using an 11-year, spatially replicated sero-survey of 3709 Peruvian vampire bats and co-occurring outbreaks in livestock.
Posted ContentDOI

Predicting the presence and titer of rabies virus neutralizing antibodies from low-volume serum samples in low-containment facilities

TL;DR: An existing micro-neutralization test is adapted to use a green fluorescent protein–tagged murine leukemia virus pseudotype in lieu of pathogenic rabies virus, reducing the need for specialized reagents for antigen detection and enabling use in low-containment laboratories.